01 1Curia
01 1ROCURONIUM BROMIDE
01 1U.S.A
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2020-06-05
Pay. Date : 2020-04-10
DMF Number : 34252
Submission : 2019-12-06
Status : Active
Type : II
20
Curia Italy Srl, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Curia- A partner for the pharma and biotech industries to improve patient outcomes & quality of life.
One of their notable products is ROCURONIUM BROMIDE, with a corresponding US DMF Number 34252.
Remarkably, this DMF maintains an Active status since its submission on December 06, 2019, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of June 05, 2020, and payment made on April 10, 2020, indicating their dedication to facilitating drug approvals, Categorized as Type II
